Conviction
$ Value
$77K
Shares
71,163
Price
$1
Filed
Sep 18
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Lettmann Jason
Title
CHIEF EXECUTIVE OFFICER
CIK
0001688269
Roles
Transaction Details
Transaction Date
2025-09-17
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
305,121
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.09, inclusive.
Filing Info
Lettmann Jason's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-14 | ALXO | A | $0 |
| 2025-09-17 | ALXO | ▲ | $77K ★ |
| 2025-09-16 | ALXO | ▲ | $22K |
| 2025-08-15 | ALXO | ▼ | $2K |
Other Insiders at ALXO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Klencke Barbara
Chief Medical Officer
|
— | — | 2026-04-16 |
|
Knight Jeff E.
Chief Dev & Operating Officer
|
— | — | 2026-04-16 |